Molecular comparison of concurrent components of high-grade dysplasia, adenocarcinoma, and sarcomatoid carcinoma in a case of sarcomatoid carcinoma of the gallbladder
Molecular comparison of concurrent components of high-grade dysplasia, adenocarcinoma, and sarcomatoid carcinoma in a case of sarcomatoid carcinoma of the gallbladder
复制标题
DOI:
10.1007/s00428-023-03524-7
复制
发表时间:
2023-03
期刊:
影响因子:
3.5
通讯作者:
K. Hirose;Y. Omori;Y. Ono;Y. Mizukami;Yoshiki Kaneko;T. Maruyama;H. Ohtani;T. Furukawa
中科院分区:
文献类型:
--
作者:
K. Hirose;Y. Omori;Y. Ono;Y. Mizukami;Yoshiki Kaneko;T. Maruyama;H. Ohtani;T. Furukawa
Detailed genetic and immunohistochemical features of a sarcomatoid carcinoma of the gallbladder were reported. Studied was a resected gallbladder tumor involving the transverse colon, which was consisted of 3 histopathological neoplastic components, i.e., high-grade dysplasia, adenocarcinoma, and sarcomatoid carcinoma. The targeted amplicon sequencing showed somatic mutations inTP53(p.S90fs) andARID1A(c.4993 + 1G > T) in all of the 3 components. Copy numbers ofCDKN2AandSMAD4were decreased in the adenocarcinoma and the sarcomatoid component. Immunohistochemistry showed loss of expression of p53 and ARID1A in all components. p16 expression was lost in the adenocarcinoma and the sarcomatoid component, while SMAD4 expression was lost only in the latter. These results suggest that this sarcomatoid carcinoma may have developed by progression from high-grade dysplasia via adenocarcinoma with sequential accumulation of molecular aberrations involving p53, ARID1A, p16, and SMAD4. This information should serve to understand the molecular mechanism of this very intractable tumor.